Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells (vol 6, pg 228, 2010)

被引：0
|
作者：
Wu, William Ka Kei
Cho, Chi Hin
Lee, Chung Wa
Wu, Ya Chun
Yu, Le
Li, Zhi Jie
Wong, Clover Ching Man
Li, Hai Tao
Zhang, Lin
Ren, Shun Xiang
Che, Chun Tao
Wu, Kaichun
Fan, Daiming
Yu, Jun
Sung, Joseph Jao Yiu
机构：
来源：
AUTOPHAGY | 2022年 / 18卷 / 03期
关键词：
D O I：
10.1080/15548627.2021.1936778
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：709 / 709
页数：1
相关论文
共 50 条
  • [1] Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells
    Wu, William Ka Kei
    Cho, Chi Hin
    Lee, Chung Wa
    Wu, Ya Chun
    Yu, Le
    Li, Zhi Jie
    Wong, Clover Ching Man
    Li, Hai Tao
    Zhang, Lin
    Ren, Shun Xiang
    Che, Chun Tao
    Wu, Kaichun
    Fan, Daiming
    Yu, Jun
    Sung, Joseph Jao Yiu
    AUTOPHAGY, 2010, 6 (02) : 228 - 238
  • [2] Macroautophagy and ERK Phosphorylation Counteract the Anti-Proliferative Effect of Proteasome Inhibitor in Gastric Cancer Cells
    Wu, William K.
    Cho, Chi-Hin
    Yu, Jun
    Sung, Joseph J.
    GASTROENTEROLOGY, 2010, 138 (05) : S440 - S440
  • [3] Antiproliferative effects of the CDK6 inhibitor PD0332991 and its effect on signaling networks in gastric cancer cells
    Wang, Daguang
    Sun, Yabin
    Li, Wei
    Ye, Fei
    Zhang, Yang
    Guo, Yuchen
    Zhang, David Y.
    Suo, Jian
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (05) : 2473 - 2484
  • [4] Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer (vol 70, pg 1970, 2010)
    Kupperman, E.
    Lee, E. C.
    Cao, Y.
    Bannerman, B.
    Fitzgerald, M.
    Berger, A.
    Yu, J.
    Yang, Y.
    Hales, P.
    Bruzzese, F.
    Liu, J.
    Blank, J.
    Garcia, K.
    Tsu, C.
    Dick, L.
    Fleming, P.
    Yu, L.
    Manfredi, M.
    Rolfe, M.
    Bolen, J.
    CANCER RESEARCH, 2010, 70 (09)
  • [5] Peritoneal macrophage priming in cirrhosis is related to ERK phosphorylation and IL-6 secretion (vol 41, pg 8, 2010)
    Tapia-Abellan, Ana
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (04) : 464 - 464
  • [6] The antitumor effect of HDAC inhibitor Tenovin-6 for gastric cancer cells
    Ueno, Takunori
    Hirai, Sachiko
    Hirose, Mitsuaki
    Endo, Shinji
    Suzuki, Hideo
    Yamato, Kenji
    Hyodo, Ichinosuke
    CANCER RESEARCH, 2012, 72
  • [7] Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells (vol 29, pg 607, 2012)
    Du, Jian
    Tang, Bo
    Wang, Jingwen
    Sui, Hongtao
    Jin, Xueli
    Wang, Liming
    Wang, Zhongyu
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2023, 52 (05)
  • [8] CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation (vol 48, pg 2184, 2016)
    Wang, Junpu
    Hu, Wanming
    Wu, Xiaoying
    Wang, Kuansong
    Yu, Jun
    Luo, Baihua
    Luo, Gengqiu
    Wang, Weiyuan
    Wang, Huiling
    Li, Jinghe
    Wen, Jifang
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 62 (06)
  • [9] RETRACTION: The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo (Retraction of Vol 115, Pg 4478, 2010)
    Dasmahapatra, G.
    Lembersky, D.
    Kramer, L.
    Fisher, R., I
    Friedberg, J.
    Dent, P.
    Grant, S.
    BLOOD, 2019, 134 (01) : 95 - 95
  • [10] The proteasome inhibitor bortezomib inhibits FGF-2-induced reduction of TAZ levels in osteoblast-like cells (vol 85, pg 68, 2010)
    Eda, Homare
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (04) : 370 - 370
12345